SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer.
Saved in:
| Title: | SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. |
|---|---|
| Authors: | Guo, Yuan1 (AUTHOR), Zhou, Xiaoli1 (AUTHOR), Xu, Haoran1 (AUTHOR), Wang, Gengfang1 (AUTHOR) wanggengfang1986@163.com |
| Source: | Scientific Reports. 11/21/2025, Vol. 15 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
